Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of LYEL will decline by -6.14% over the next 2 Weeks and hit $12.62 by Wednesday, August 19, 2026. In that time frame, LYEL's share price is expected to range between $11.82 and $13.42.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 19, 2026 | 11.82 | 12.62 | 13.42 |
| Aug 18, 2026 | 12.05 | 12.79 | 13.59 |
| Aug 17, 2026 | 11.62 | 12.39 | 13.18 |
| Aug 14, 2026 | 11.66 | 12.46 | 13.26 |
| Aug 13, 2026 | 12.31 | 13.09 | 13.86 |
| Aug 12, 2026 | 12.27 | 13.03 | 13.73 |
| Aug 11, 2026 | 12.46 | 13.20 | 13.91 |
| Aug 10, 2026 | 12.05 | 12.79 | 13.58 |
| Aug 7, 2026 | 12.11 | 12.87 | 13.60 |
| Aug 6, 2026 | 12.78 | 13.50 | 14.25 |
LYEL shares rose +5.65% in Thursday, August 6, 2026's trading session, rising from a previous close of $13.45 to move at $14.21. The stock demonstrated notable intraday movement (see LYEL's key stats for a full breakdown), fluctuating between $13.85 and $15.64, a +12.92% trading range. While recent weeks have seen some volatility, LYEL has managed to secure a +12.51% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 357.04K shares changing hands, 127.65K fewer than the previous session. This amounted to $5.07M in total market activity.
Will LYEL Continue Its Downward Trend?
According to analyst ratings and projections for LYEL, Lyell Immunopharma, Inc. shares are anticipated to decrease by -5.87%, potentially reaching $13.42 per share by August 19, 2026. Short-term technical indicators currently suggest a neutral sentiment for LYEL. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the LYEL stock forecast, now is not the best time to buy LYEL stock because its current trading price is +12.56% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on LYEL covering social and institutional perspectives.
LYEL Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into LYEL's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 51.17% to 61.04%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 46.46%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.37%, maintains a neutral outlook for the long term. Insights into LYEL's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Lyell Immunopharma Short-Term Forecasts
LYEL Forecast For Next 5 Days
Our algorithm anticipates Lyell Immunopharma (LYEL) stock could hit $13.20 by Aug 13, 2026. This represents a -7.09% rise from today's price, following a +0.55% change over the past five days.
LYEL Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Lyell Immunopharma, Inc. (LYEL) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $11.80, which would mean a -16.96% decrease from the current price of $14.21. Projections for this period range from a high of $15.77 to a low of $8.15.
LYEL Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Lyell Immunopharma's price over the next three months point to a drop. LYEL stock is expected to peak at $17.43 on Aug 06, 2026 before potentially dipping to $10.68 on Nov 06, 2026. On average, LYEL is likely to trade around $13.68 in the coming 90 days.
Lyell Immunopharma Stock Forecast 2025
Based on our predictive models, Lyell Immunopharma (LYEL) is expected to trade between $6.79 and $17.43 throughout 2026. This would result in an average price of $12.42, potentially offering investors a -12.60% return from current levels.
Lyell Immunopharma, Inc. Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, Lyell Immunopharma, Inc. (LYEL) is positioned to show a strong performance in August 2026. The price is predicted to move between $13.23 and $17.43, settling at an average of $14.76. This could translate to a +3.87% gain.
September 2026
Based on current market signals, Lyell Immunopharma, Inc. is projected to trend september 2026. We forecast a trading range from $11.77 to $15.17, with a likely average price of $13.32. Investors could expect a potential return of -6.26%.
October 2026
Our predictive algorithms indicate Lyell Immunopharma, Inc. stock may see a shift in October 2026. The expected range spans $11.09–$15.41, with an average target of $13.48. This represents a cautious outlook and a possible loss of -5.14%.
November 2026
Analyzing established trends, Lyell Immunopharma, Inc. looks set to move in November 2026. Projections place the stock between $7.86 and $13.52, averaging around $11.09. This suggests a -21.96% loss from current levels.
December 2026
Market indicators suggest Lyell Immunopharma, Inc. could experience notable changes during December 2026. Prices could fluctuate within $6.79 to $11.61, with a midpoint forecast of $9.95. The stock might deliver a -29.98% loss.
January 2027
Forecasting for January 2027, models estimate that Lyell Immunopharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $4.66 and $9.80, averaging $8.21. This signals a cautious trajectory with potential returns around -42.22%.
February 2027
According to our latest forecast models, Lyell Immunopharma, Inc. (LYEL) is positioned to show a strong performance in February 2027. The price is predicted to move between $4.13 and $9.87, settling at an average of $8.30. This could translate to a -41.59% loss.
March 2027
Based on current market signals, Lyell Immunopharma, Inc. is projected to trend march 2027. We forecast a trading range from $1.59 to $9.83, with a likely average price of $8.66. Investors could expect a potential return of -39.06%.
April 2027
Our predictive algorithms indicate Lyell Immunopharma, Inc. stock may see a shift in April 2027. The expected range spans $0.00–$6.48, with an average target of $6.43. This represents a cautious outlook and a possible loss of -54.75%.
May 2027
Analyzing established trends, Lyell Immunopharma, Inc. looks set to move in May 2027. Projections place the stock between $0.00 and $4.35, averaging around $5.40. This suggests a -62.00% loss from current levels.
June 2027
Market indicators suggest Lyell Immunopharma, Inc. could experience notable changes during June 2027. Prices could fluctuate within $0.00 to $3.04, with a midpoint forecast of $4.32. The stock might deliver a -69.60% loss.
July 2027
Forecasting for July 2027, models estimate that Lyell Immunopharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.30, averaging $3.90. This signals a cautious trajectory with potential returns around -72.55%.
August 2027
According to our latest forecast models, Lyell Immunopharma, Inc. (LYEL) is positioned to show a strong performance in August 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $3.84. This could translate to a -72.98% loss.
LYEL's history of dividends and stock splits also plays a role in long-term investor confidence.

